Risk estimation for recurrent Clostridium difficile infection based on clinical factors

Area of Science:

• Infectious Diseases
• Clinical Epidemiology
• Biostatistics

Background:

• Rising incidence of Clostridium difficile infection (CDI) presents a significant public health challenge.
• Despite effective treatments like vancomycin, 20-30% of patients experience recurrent CDI.
• Identifying patients at high risk for recurrence is crucial for optimizing treatment strategies.

Purpose of the Study:

• To develop a practical scoring rule for predicting recurrent CDI.
• To identify key independent risk factors for CDI recurrence.
• To aid clinicians in making informed treatment decisions for CDI patients.

Main Methods:

• Logistic regression modeling was employed using data from two large Phase 3 clinical trials.
• Seventy-seven baseline factors were assessed, including demographics, comorbidities, medications, and clinical parameters.
• Stepwise selection and receiver operating characteristic (ROC) curve analysis were used to identify significant predictors.

Main Results:

• A predictive model incorporating four independent risk factors was developed: age, stool frequency, serum creatinine, and history of prior CDI.
• The choice of treatment (vancomycin or fidaxomicin) was also included in the final model.
• These factors are readily available at initial patient contact, enhancing clinical utility.

Conclusions:

• The developed prediction model offers a practical tool for assessing the risk of CDI recurrence.
• This scoring rule may assist healthcare providers in tailoring treatment decisions for individual patients.
• Further validation could support its integration into routine clinical practice for CDI management.